Show simple item record

Chronic use of benzodiazepines and psychomotor and cognitive test performance

dc.contributor.authorLucki, Irwinen_US
dc.contributor.authorGeller, Andrew M.en_US
dc.contributor.authorRickels, Karlen_US
dc.date.accessioned2006-09-11T17:47:02Z
dc.date.available2006-09-11T17:47:02Z
dc.date.issued1986-04en_US
dc.identifier.citationLucki, Irwin; Rickels, Karl; Geller, Andrew M.; (1986). "Chronic use of benzodiazepines and psychomotor and cognitive test performance." Psychopharmacology 88(4): 426-433. <http://hdl.handle.net/2027.42/46439>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46439
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2871579&dopt=citationen_US
dc.description.abstractThe performance of 43 long-term users (average = 5 years) of benzodiazepine (BZ) medications was examined on a battery of behavioral tasks, cognitive tests, and subjective mood rating scales. The performance of the chronic BZ users did not differ significantly from age- and sex-matched anxious subjects, except that critical flicker fusion (CFF) thresholds were lower and subjective ratings of tranquilization were higher in the BZ users. Twenty-two subjects were reexamined in order to determine the acute effects of BZ medications in long-term users. The acute administration of BZ medications significantly increased CFF thresholds, improved digit-symbol substitution test performance, impaired the delayed recall of verbal material, increased subjective ratings of tranquilization, and reduced physical sedation. Motor performance tests were not impaired and subjective feelings of sedation were not increased after the acute administration of BZs by chronic users. During withdrawal from long-term BZ use (17 subjects), CFF thresholds were elevated, subjective ratings of physical sedation and anxiety were increased, but performance on other psychomotor and cognitive tests was not altered. The results suggest that tolerance develops selectively to different behavioral and subjective effects of BZ medications with their continued use. Tolerance failed to develop to the antianxiety effects, the reduction of CFF threshold, and to the impairment of short-term memory caused by BZs. However, chronic users of BZ medications failed to demonstrate psychomotor-impairing or sedating effects to BZ medications. The results have implications for evaluating the safety of the long-term use of BZ medications.en_US
dc.format.extent1046954 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherPsychomotor Performanceen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBenzodiazepinesen_US
dc.subject.otherChronic Drug Useen_US
dc.subject.otherAnxietyen_US
dc.subject.otherMemoryen_US
dc.titleChronic use of benzodiazepines and psychomotor and cognitive test performanceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry, University of Pennsylvania School of Medicine, 19104, Philadelphia, PA, USA; Department of Psychology, University of Michigan, 48104, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Psychiatry, University of Pennsylvania School of Medicine, 19104, Philadelphia, PA, USA; Psychopharmacology Research and Treatment Clinic, 133 South 36th St. Room 402, 19104, Philadelphia, PA, USAen_US
dc.contributor.affiliationotherDepartment of Psychiatry, University of Pennsylvania School of Medicine, 19104, Philadelphia, PA, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid2871579en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46439/1/213_2004_Article_BF00178503.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00178503en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.